Skip to main content

Sae reconciliation

 SAE Reconciliation


Serious adverse event (SAE) reconciliation is one of the critical activities in clinical data management & also an important activity for clinical data manager.




Let's explore.

Why SAE reconciliation ?

Primary reason is to ensure the patient safety and integrity of clinical trial data, by comparing the SAE's reported between EDC and safety database for its completeness, accuracy & classification.

Steps in SAE Reconciliation

1. 𝗦𝗔𝗘 𝗿𝗲𝗰𝗼𝗻𝗰𝗶𝗹𝗶𝗮𝘁𝗶𝗼𝗻 𝗽𝗹𝗮𝗻: This can be documented as part of DMP or it can be standalone document & It covers imp items like
a. Process & roles involved in SAE recon
b. List of items to be reconciled
c. Process to report discrepancies
d. Action to take to correct the data in both databases

2. 𝗖𝗼𝗺𝗽𝗮𝗿𝗲 𝘁𝗵𝗲 𝗦𝗔𝗘 𝗱𝗮𝘁𝗮 𝗯/𝘄 𝟮 𝘀𝗼𝘂𝗿𝗰𝗲𝘀:

Receive SAE dump or monthly SAE report from safety team & review the same for discrepancies in EDC data for the data points including

From Adverse Event (AE) form:

a. Protocol & Subject Number
b. AE Term (Both reported terms & coded term)
c. Severity Grade
d. Start & End dates
e. Death date (if any)
f. Outcome
g. Seriousness criteria
h. Relation to the drug
i. Action taken with study drug

From Demographics (DM):

a. DOB
b. Age
c. Sex
d. Race

From Concomitant Medication (CM) & Medical History (MH)

a. Medication name / Medical condition / Surgery
b. Start date
c. Stop date or ongoing Indication

From Study / Treatment Discontinuation (DS)

a. Primary reason for discontinuation being an event
b. Cause of hospitalization
c. Cause of death listed on the death certificate
d. Autopsy result

𝟯. 𝗧𝗮𝗸𝗲 𝗮𝗽𝗽𝗿𝗼𝗽𝗮𝗿𝗶𝘁𝗲 𝗮𝗰𝘁𝗶𝗼𝗻 𝗻𝗲𝗲𝗱𝗲𝗱 𝗯𝗮𝘀𝗲𝗱 𝗼𝗻 𝘁𝗵𝗲 𝗱𝗶𝘀𝗰𝗽𝗿𝗲𝗻𝗰𝗲𝗶𝘀 .

Lets see the major SAE reconciliation Errors found in SAE Reconciliation

𝟭. 𝗗𝗮𝘁𝗮 𝗲𝗻𝘁𝗿𝘆 𝗲𝗿𝗿𝗼𝗿𝘀: This can occur due to human error, transcription errors, or incorrect data entry fields.

𝟮. 𝗜𝗻𝗰𝗼𝗺𝗽𝗹𝗲𝘁𝗲 𝗱𝗮𝘁𝗮: Incomplete SAE data can occur when events are not recorded in both the EDC and safety databases

𝟯. 𝗜𝗻𝗰𝗼𝗻𝘀𝗶𝘀𝘁𝗲𝗻𝗰𝗶𝗲𝘀 𝗶𝗻 𝗰𝗼𝗱𝗶𝗻𝗴: SAEs may be coded differently in the EDC and safety databases, leading to discrepancies

𝟰. 𝗜𝗻𝗰𝗼𝗻𝘀𝗶𝘀𝘁𝗲𝗻𝗰𝗶𝗲𝘀 𝗶𝗻 𝗿𝗲𝗽𝗼𝗿𝘁𝗶𝗻𝗴: this can happen when different investigators or study sites use different terminology or criteria for reporting SAE

𝟱. 𝗗𝗲𝗹𝗮𝘆𝗲𝗱 𝗿𝗲𝗽𝗼𝗿𝘁𝗶𝗻𝗴: this may lead to a backlog of events to be reconciled.

In many companies SAE reconciliations are now done automatically with set of programs & DM's will verify the output report from these programs for their accuracy and reconcile manually in case its needed.
Labels:

Comments

Post a Comment

Popular posts from this blog

Difference between central lab and Local Lab

 In the context of clinical trials, both central laboratories (central labs) and local laboratories (local labs) play essential roles in processing and analyzing biological samples. However, they differ significantly in their operations, advantages, and applications. Here’s a detailed comparison: ### Central Laboratory **Definition:** A central laboratory is a large, centralized facility that processes and analyzes samples from multiple sites participating in a clinical trial. These labs are usually equipped with advanced technology and staffed by highly trained personnel. **Key Characteristics:** - **Standardization:** Central labs offer standardized procedures and protocols, ensuring consistent and uniform testing across all samples. - **Quality Control:** They maintain stringent quality control measures, often accredited by recognized bodies (e.g., CAP, CLIA). - **Advanced Technology:** Equipped with state-of-the-art equipment and specialized assays, central labs can perform a w...
Post a Comment
Read more

clinical data management in Clinical research

 Certainly! Below is an expanded and detailed discussion on clinical data management (CDM) that would cover approximately. --- # Clinical Data Management (CDM) in Clinical Research ## Introduction Clinical Data Management (CDM) is an integral part of the clinical research process, focusing on the collection, cleaning, and management of data generated during clinical trials. The primary objective is to ensure that data is accurate, complete, and reliable, supporting robust conclusions and regulatory submissions. This document provides a comprehensive overview of CDM, including its key components, tools, regulatory and ethical considerations, challenges, and future trends. ## Key Components of Clinical Data Management ### 1. Study Protocol Development The study protocol is the cornerstone of any clinical trial, outlining the study’s objectives, design, methodology, and statistical considerations.  #### Protocol Design - **Objective Setting**: Clearly defining the research questi...
Post a Comment
Read more

study start up

  STUDY START UP/STUDY SET UP: eCRF(case report form): The case report form is a printed or electronic questionnaire for collecting data from study participants and reporting it to trial sponsors. The document is created specifically for each research project in accordance with the trial protocol, and recommendations of the Clinical Data Acquisitions Standards Harmonization (CDASH). They are developed by Clinical Data Interchange Standards Consortium to streamline industry-wide data exchange. Say, CDASH dictates dd/mm/yy format for collecting dates. (Read our article on CDISC standards to learn more.) Well-designed case report forms collect only data necessary for the particular study avoiding any redundancy. The fields to be filled in may include demographics (age, gender), basic measurements (height, weight), vital signs (blood pressure, temperature, etc.) captured at various time points, lab exams, medical history, adverse events, and more, based on the research requirements....
Post a Comment
Read more